Divalent 2-(4-Hydroxyphenyl)benzothiazole Bifunctional Chelators for 64Cu Positron Emission Tomography Imaging in Alzheimer's Disease.

Herein, we report a new series of divalent 2-(4-hydroxyphenyl)benzothiazole bifunctional chelators (BFCs) with high affinity for amyloid β aggregates and favorable lipophilicity for blood-brain barrier penetration. The addition of an alkyl carboxylate ester pendant arm offers high binding affinity toward Cu(II). The novel BFCs form stable 64Cu-radiolabeled complexes and exhibit promising partition coefficient (logD) values of 1.05-1.85. Among the five compounds tested, the 64Cu-YW-15 complex exhibits significant staining of amyloid β plaques in ex vivo autoradiography studies. In addition, biodistribution studies show that 64Cu-YW-15-Me exhibits moderate brain uptake (0.69 ± 0.08 %ID/g) in wild type mice.

[1]  B. Rogers,et al.  68Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy , 2022, ACS omega.

[2]  B. Rogers,et al.  Amyloid β-Binding Bifunctional Chelators with Favorable Lipophilicity for 64Cu Positron Emission Tomography Imaging in Alzheimer's Disease. , 2021, Inorganic chemistry.

[3]  E. Tajkhorshid,et al.  Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease. , 2021, Journal of the American Chemical Society.

[4]  A. Majouga,et al.  Metals in Imaging of Alzheimer’s Disease , 2020, International journal of molecular sciences.

[5]  B. Rogers,et al.  Design of a multivalent bifunctional chelator for diagnostic 64Cu PET imaging in Alzheimer’s disease , 2020, Proceedings of the National Academy of Sciences.

[6]  A. Sharma,et al.  Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ42 Oligomers. , 2020, ACS chemical neuroscience.

[7]  B. C. Uzuegbunam,et al.  PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape , 2020, Molecules.

[8]  D. Dickson,et al.  The neuropathological diagnosis of Alzheimer’s disease , 2019, Molecular Neurodegeneration.

[9]  M. G. Savelieff,et al.  Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. , 2018, Chemical reviews.

[10]  G. Gasser,et al.  Harnessing the Coordination Chemistry of 1,4,7-Triazacyclononane for Biomimicry and Radiopharmaceutical Applications. , 2018, ChemPlusChem.

[11]  Kamila Czarnecka,et al.  New Perspectives of Alzheimer Disease Diagnosis - the Most Popular and Future Methods. , 2018, Medicinal chemistry (Shariqah (United Arab Emirates)).

[12]  A. Sharma,et al.  Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in 64Cu PET Imaging for Alzheimer’s Disease , 2017, Inorganic chemistry.

[13]  A. Sharma,et al.  Evaluation of 64Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease , 2017, Journal of the American Chemical Society.

[14]  R. Tripier,et al.  1,4,7‐Triazacyclononane‐Based Bifunctional Picolinate Ligands for Efficient Copper Complexation , 2017 .

[15]  Norelle C. Wildburger,et al.  Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains , 2016, Scientific Reports.

[16]  T. Wisniewski,et al.  Alzheimer’s disease: experimental models and reality , 2017, Acta Neuropathologica.

[17]  Maurizio Conti,et al.  Physics of pure and non-pure positron emitters for PET: a review and a discussion , 2016, EJNMMI Physics.

[18]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[19]  J. Šimeček,et al.  The Influence of the Combination of Carboxylate and Phosphinate Pendant Arms in 1,4,7-Triazacyclononane-Based Chelators on Their 68Ga Labelling Properties , 2015, Molecules.

[20]  M. Sabbagh,et al.  Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain , 2014, Neurology and Therapy.

[21]  J. Dubroff,et al.  An overview of PET neuroimaging. , 2013, Seminars in nuclear medicine.

[22]  James L. Hickey,et al.  Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaques. , 2013, Journal of the American Chemical Society.

[23]  D. Holtzman,et al.  Traumatic brain injury reduces soluble extracellular amyloid-β in mice: A methodologically novel combined microdialysis-controlled cortical impact study , 2010, Neurobiology of Disease.

[24]  C. Anderson,et al.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.

[25]  A. Fagan,et al.  Cerebrospinal fluid biomarkers of Alzheimer's disease. , 2010, Biomarkers in medicine.

[26]  Tyler E. Benedum,et al.  Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain , 2009, Journal of Nuclear Medicine.

[27]  A. Fagan,et al.  Multimodal techniques for diagnosis and prognosis of Alzheimer's disease , 2009, Nature.

[28]  H. Jacobsen,et al.  Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.

[29]  G. Bormans,et al.  11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease. , 2009, European journal of medicinal chemistry.

[30]  L. Mortelmans,et al.  Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease. , 2009, Journal of medicinal chemistry.

[31]  W. Klunk,et al.  Imaging β-Amyloid Plaques and Neurofibrillary Tangles in the Aging Human Brain , 2004 .

[32]  A. J. Blake,et al.  Synthesis and characterisation of pendant-arm amino derivatives of 1,4,7-triazacyclononane and alkyl-bridged bis(1,4,7-triazacyclononane) macrocycles and complexation to Cu(II) , 2000 .

[33]  J. Pettegrew,et al.  Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.